Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 215,200 shares at $13.03 ($2.9M) on 2020-09-28, disclosed to the SEC on 2020-09-30.
Open-market purchase of $2.9M ODT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.03 | 93,200 | $1.2M | 41.4% |
| 2 | $14.08 | 122,000 | $1.7M | 58.6% |
| Total | $13.63 avg | 215,200 | $2.9M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |